The emergence of novel psychoactive substances offers a unique challenge for researchers and policymakers alike. Among these, 2-FDCK has risen prominence as a potent dissociative agent with unknown pharmacological properties. Initial studies suggest that 2-FDCK may produce analogous effects to other dissociatives, such as ketamine, but its precise